Obstructing Colon Cancer

A specific presentation of colorectal cancer, distinct from — but related to — Large Bowel Obstruction in general. Content below is from a textbook reference chapter (Sabiston Ch52 - Colorectal Neoplasia & Colon Cancer Surgery), not primary literature.

Presentation and diagnosis

Patients may present indolently — pencil-thin stools, increasing constipation, an increasingly distended abdomen — or acutely, with obstipation, complete obstruction, abdominal pain, and vomiting (which may become feculent). Diagnosis is commonly confirmed with plain films, contrast enemas, abdominal CT, and lower endoscopy. Treatment objectives: relieve the obstruction, resect any ischemic/nonviable bowel, and resect the tumor.

Management of left-sided obstructions

The approach is tailored to the location of the obstruction, viability of the proximal bowel, and the patient's general stability. Patients with sigmoid and left colon obstructions are commonly referred for urgent surgery. A segmental resection of the primary tumor is typically performed. If the proximal large bowel has perforated or shows ischemia, a subtotal colectomy is completed instead.

Historically, primary anastomosis was avoided in this setting: the distal stump was closed and a proximal stoma exteriorized (Hartmann's operation). However, reestablishing continuity later requires a major operation, and a large proportion of these patients are never reversed. Current evidence supports primary anastomosis as an option in hemodynamically stable, appropriate patients — a tension-free anastomosis with good blood supply can be achieved by specialized surgeons, with leak rates in the range of 2–12% (almost comparable to the 2–8% leak rate seen in elective surgery). Intraoperative colonic lavage and manual decompression prior to anastomosis give similar results to each other, though evidence is lacking to support either specifically for reducing anastomotic leak or infectious complications. A proximal diverting stoma may also be exteriorized in combination with a primary anastomosis — this doesn't reduce the anastomotic leak rate itself, but may decrease the number of leaks that require reoperation.

Endoscopic stenting as a bridge to surgery has emerged as an attractive technique to relieve the obstruction and allow elective surgery under more favorable conditions. Stenting has been shown to permit higher rates of primary anastomosis, decreased wound infections, and a higher rate of laparoscopic completion of surgery. Stenting is contraindicated in suspected ischemic or perforated bowel. Clinical success is in the 70–80% range, with the main immediate risk being stent-related perforation. Concerns about inferior long-term oncologic outcomes have historically limited its use in patients with average-risk, curable disease, although recent evidence suggests long-term oncologic outcomes may be acceptable. Current guidelines recommend stenting as a bridge to surgery on an individual basis, mainly in high-risk patients, to allow optimization before an interval colectomy. Endoscopic Polypectomy, EMR & ESD (ASCRS Ch. 5) corroborates and sharpens this: the specific guideline in question is ESGE 2014, which recommends against stenting as the preferred bridge-to-surgery method in an otherwise-healthy patient but supports considering it for ASA ≥3 or age >70 — consistent with, and more specific than, "mainly in high-risk patients" above. That chapter also gives numeric complication rates not detailed here: perforation 5%, migration 4–10%, repeat obstruction 30%.

Management of right-sided obstructions

Generally managed with an oncologic segmental resection. In most cases, a primary ileocolic anastomosis can be performed safely; for patients at high risk of anastomotic failure, a diverting stoma can be exteriorized instead.

Related pages

• Colon Cancer Resection — additional procedural technical detail on this page's management options (mucus fistula construction, closed distal segment handling, subtotal colectomy indication by proximal-ischemia status) added from ASCRS Ch25 - Colon Cancer Surgical Treatment, which substantially overlaps this page's content and was reconciled there rather than duplicated here.

Open items / gaps

• No primary trial data yet comparing stenting-as-bridge vs. straight-to-surgery outcomes — both Sabiston and ASCRS Ch. 5 describe evolving guideline positions (with ASCRS naming the specific ESGE 2014 guideline and two RCTs that closed early for stent complications) without either being independently ingested/appraised here yet. This is a genuinely active area of debate worth a dedicated primary-literature source.
• No comparative leak-rate data specifically for left-sided obstructive resections with vs. without proximal diversion.